量化脓毒症相关急性肾损伤替代定义对其发病率和结果的影响:系统回顾与元分析》。

IF 7.7 1区 医学 Q1 CRITICAL CARE MEDICINE Critical Care Medicine Pub Date : 2024-08-01 Epub Date: 2024-04-01 DOI:10.1097/CCM.0000000000006284
Lachlan H Donaldson, Ruan Vlok, Ken Sakurai, Morgan Burrows, Gabrielle McDonald, Karthik Venkatesh, Sean M Bagshaw, Rinaldo Bellomo, Anthony Delaney, John Myburgh, Naomi E Hammond, Balasubramanian Venkatesh
{"title":"量化脓毒症相关急性肾损伤替代定义对其发病率和结果的影响:系统回顾与元分析》。","authors":"Lachlan H Donaldson, Ruan Vlok, Ken Sakurai, Morgan Burrows, Gabrielle McDonald, Karthik Venkatesh, Sean M Bagshaw, Rinaldo Bellomo, Anthony Delaney, John Myburgh, Naomi E Hammond, Balasubramanian Venkatesh","doi":"10.1097/CCM.0000000000006284","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To derive a pooled estimate of the incidence and outcomes of sepsis-associated acute kidney injury (SA-AKI) in ICU patients and to explore the impact of differing definitions of SA-AKI on these estimates.</p><p><strong>Data sources: </strong>Medline, Medline Epub, EMBASE, and Cochrane CENTRAL between 1990 and 2023.</p><p><strong>Study selection: </strong>Randomized clinical trials and prospective cohort studies of adults admitted to the ICU with either sepsis and/or SA-AKI.</p><p><strong>Data extraction: </strong>Data were extracted in duplicate. Risk of bias was assessed using adapted standard tools. Data were pooled using a random-effects model. Heterogeneity was assessed by using a single covariate logistic regression model. The primary outcome was the proportion of participants in ICU with sepsis who developed AKI.</p><p><strong>Data synthesis: </strong>A total of 189 studies met inclusion criteria. One hundred fifty-four reported an incidence of SA-AKI, including 150,978 participants. The pooled proportion of patients who developed SA-AKI across all definitions was 0.40 (95% CI, 0.37-0.42) and 0.52 (95% CI, 0.48-0.56) when only the Risk Injury Failure Loss End-Stage, Acute Kidney Injury Network, and Improving Global Outcomes definitions were used to define SA-AKI. There was significant variation in the incidence of SA-AKI depending on the definition of AKI used and whether AKI defined by urine output criteria was included; the incidence was lowest when receipt of renal replacement therapy was used to define AKI (0.26; 95% CI, 0.24-0.28), and highest when the Acute Kidney Injury Network score was used (0.57; 95% CI, 0.45-0.69; p < 0.01). Sixty-seven studies including 29,455 participants reported at least one SA-AKI outcome. At final follow-up, the proportion of patients with SA-AKI who had died was 0.48 (95% CI, 0.43-0.53), and the proportion of surviving patients who remained on dialysis was 0.10 (95% CI, 0.04-0.17).</p><p><strong>Conclusions: </strong>SA-AKI is common in ICU patients with sepsis and carries a high risk of death and persisting kidney impairment. The incidence and outcomes of SA-AKI vary significantly depending on the definition of AKI used.</p>","PeriodicalId":10765,"journal":{"name":"Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":7.7000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Quantifying the Impact of Alternative Definitions of Sepsis-Associated Acute Kidney Injury on its Incidence and Outcomes: A Systematic Review and Meta-Analysis.\",\"authors\":\"Lachlan H Donaldson, Ruan Vlok, Ken Sakurai, Morgan Burrows, Gabrielle McDonald, Karthik Venkatesh, Sean M Bagshaw, Rinaldo Bellomo, Anthony Delaney, John Myburgh, Naomi E Hammond, Balasubramanian Venkatesh\",\"doi\":\"10.1097/CCM.0000000000006284\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To derive a pooled estimate of the incidence and outcomes of sepsis-associated acute kidney injury (SA-AKI) in ICU patients and to explore the impact of differing definitions of SA-AKI on these estimates.</p><p><strong>Data sources: </strong>Medline, Medline Epub, EMBASE, and Cochrane CENTRAL between 1990 and 2023.</p><p><strong>Study selection: </strong>Randomized clinical trials and prospective cohort studies of adults admitted to the ICU with either sepsis and/or SA-AKI.</p><p><strong>Data extraction: </strong>Data were extracted in duplicate. Risk of bias was assessed using adapted standard tools. Data were pooled using a random-effects model. Heterogeneity was assessed by using a single covariate logistic regression model. The primary outcome was the proportion of participants in ICU with sepsis who developed AKI.</p><p><strong>Data synthesis: </strong>A total of 189 studies met inclusion criteria. One hundred fifty-four reported an incidence of SA-AKI, including 150,978 participants. The pooled proportion of patients who developed SA-AKI across all definitions was 0.40 (95% CI, 0.37-0.42) and 0.52 (95% CI, 0.48-0.56) when only the Risk Injury Failure Loss End-Stage, Acute Kidney Injury Network, and Improving Global Outcomes definitions were used to define SA-AKI. There was significant variation in the incidence of SA-AKI depending on the definition of AKI used and whether AKI defined by urine output criteria was included; the incidence was lowest when receipt of renal replacement therapy was used to define AKI (0.26; 95% CI, 0.24-0.28), and highest when the Acute Kidney Injury Network score was used (0.57; 95% CI, 0.45-0.69; p < 0.01). Sixty-seven studies including 29,455 participants reported at least one SA-AKI outcome. At final follow-up, the proportion of patients with SA-AKI who had died was 0.48 (95% CI, 0.43-0.53), and the proportion of surviving patients who remained on dialysis was 0.10 (95% CI, 0.04-0.17).</p><p><strong>Conclusions: </strong>SA-AKI is common in ICU patients with sepsis and carries a high risk of death and persisting kidney impairment. The incidence and outcomes of SA-AKI vary significantly depending on the definition of AKI used.</p>\",\"PeriodicalId\":10765,\"journal\":{\"name\":\"Critical Care Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":7.7000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Care Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/CCM.0000000000006284\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/4/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CCM.0000000000006284","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/1 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

目的:对 ICU 患者脓毒症相关急性肾损伤(SA-AKI)的发生率和结局进行汇总估计,并探讨不同的 SA-AKI 定义对这些估计值的影响:数据来源:1990 年至 2023 年间的 Medline、Medline Epub、EMBASE 和 Cochrane CENTRAL:随机临床试验和前瞻性队列研究,研究对象为因脓毒症和/或 SA-AKI 而入住 ICU 的成人:数据提取:一式两份。使用改编的标准工具评估偏倚风险。采用随机效应模型对数据进行汇总。采用单一协变量逻辑回归模型评估异质性。主要结果是脓毒症重症监护病房中出现 AKI 的参与者比例:共有 189 项研究符合纳入标准。154项研究报告了SA-AKI的发生率,包括150978名参与者。在所有定义中,发生SA-AKI的患者的总比例为0.40(95% CI,0.37-0.42),而在仅使用 "风险损伤失败终末期"、"急性肾损伤网络 "和 "改善全球结局 "定义来定义SA-AKI时,发生SA-AKI的患者的总比例为0.52(95% CI,0.48-0.56)。根据所使用的 AKI 定义以及是否包括以尿量标准定义的 AKI,SA-AKI 的发生率存在明显差异;当使用接受肾脏替代治疗来定义 AKI 时,发生率最低(0.26;95% CI,0.24-0.28),而当使用急性肾损伤网络评分时,发生率最高(0.57;95% CI,0.45-0.69;P <0.01)。包括 29,455 名参与者在内的 67 项研究报告了至少一项 SA-AKI 结果。在最终随访中,SA-AKI患者死亡的比例为0.48(95% CI,0.43-0.53),存活患者继续透析的比例为0.10(95% CI,0.04-0.17):SA-AKI在ICU脓毒症患者中很常见,具有很高的死亡和持续肾功能损害风险。SA-AKI的发生率和结果因所使用的AKI定义不同而有很大差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Quantifying the Impact of Alternative Definitions of Sepsis-Associated Acute Kidney Injury on its Incidence and Outcomes: A Systematic Review and Meta-Analysis.

Objectives: To derive a pooled estimate of the incidence and outcomes of sepsis-associated acute kidney injury (SA-AKI) in ICU patients and to explore the impact of differing definitions of SA-AKI on these estimates.

Data sources: Medline, Medline Epub, EMBASE, and Cochrane CENTRAL between 1990 and 2023.

Study selection: Randomized clinical trials and prospective cohort studies of adults admitted to the ICU with either sepsis and/or SA-AKI.

Data extraction: Data were extracted in duplicate. Risk of bias was assessed using adapted standard tools. Data were pooled using a random-effects model. Heterogeneity was assessed by using a single covariate logistic regression model. The primary outcome was the proportion of participants in ICU with sepsis who developed AKI.

Data synthesis: A total of 189 studies met inclusion criteria. One hundred fifty-four reported an incidence of SA-AKI, including 150,978 participants. The pooled proportion of patients who developed SA-AKI across all definitions was 0.40 (95% CI, 0.37-0.42) and 0.52 (95% CI, 0.48-0.56) when only the Risk Injury Failure Loss End-Stage, Acute Kidney Injury Network, and Improving Global Outcomes definitions were used to define SA-AKI. There was significant variation in the incidence of SA-AKI depending on the definition of AKI used and whether AKI defined by urine output criteria was included; the incidence was lowest when receipt of renal replacement therapy was used to define AKI (0.26; 95% CI, 0.24-0.28), and highest when the Acute Kidney Injury Network score was used (0.57; 95% CI, 0.45-0.69; p < 0.01). Sixty-seven studies including 29,455 participants reported at least one SA-AKI outcome. At final follow-up, the proportion of patients with SA-AKI who had died was 0.48 (95% CI, 0.43-0.53), and the proportion of surviving patients who remained on dialysis was 0.10 (95% CI, 0.04-0.17).

Conclusions: SA-AKI is common in ICU patients with sepsis and carries a high risk of death and persisting kidney impairment. The incidence and outcomes of SA-AKI vary significantly depending on the definition of AKI used.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Critical Care Medicine
Critical Care Medicine 医学-危重病医学
CiteScore
16.30
自引率
5.70%
发文量
728
审稿时长
2 months
期刊介绍: Critical Care Medicine is the premier peer-reviewed, scientific publication in critical care medicine. Directed to those specialists who treat patients in the ICU and CCU, including chest physicians, surgeons, pediatricians, pharmacists/pharmacologists, anesthesiologists, critical care nurses, and other healthcare professionals, Critical Care Medicine covers all aspects of acute and emergency care for the critically ill or injured patient. Each issue presents critical care practitioners with clinical breakthroughs that lead to better patient care, the latest news on promising research, and advances in equipment and techniques.
期刊最新文献
Time Controlled Adaptive Ventilation/Airway Pressure Release Ventilation Can be Used Effectively in Patients With or at High Risk of Acute Respiratory Distress Syndrome "Time is the Soul of the World" Pythagoras. Caution-Do Not Attempt This at Home. Airway Pressure Release Ventilation Should Not Routinely Be Used in Patients With or at Risk of Acute Respiratory Distress Syndrome Outside of a Clinical Trial. Resuscitation for Donation After Brain Death: Respecting Autonomy and Maximizing Utility. Cardiopulmonary Resuscitation for Organ Preservation After Death Risks Public Trust and Requires Explicit Consent. Two Weeks Versus One Week of Maximal Patient-Intensivist Continuity for Adult Medical Intensive Care Patients: A Two-Center Target Trial Emulation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1